位置:首页 > 蛋白库 > ANSME_BACTN
ANSME_BACTN
ID   ANSME_BACTN             Reviewed;         414 AA.
AC   Q02550;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   11-APR-2003, sequence version 2.
DT   03-AUG-2022, entry version 128.
DE   RecName: Full=Serine-type anaerobic sulfatase-maturating enzyme {ECO:0000305};
DE            Short=Ser-type anaerobic sulfatase-maturating enzyme {ECO:0000305};
DE            EC=1.1.98.7 {ECO:0000269|PubMed:18408004};
DE   AltName: Full=Anaerobic sulfatase-maturating enzyme {ECO:0000303|PubMed:18408004};
DE            Short=AnSME {ECO:0000303|PubMed:18408004};
DE   AltName: Full=Chondroitin sulfate/heparin utilization regulation protein;
GN   Name=chuR; OrderedLocusNames=BT_0238;
OS   Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 /
OS   CCUG 10774 / NCTC 10582 / VPI-5482 / E50).
OC   Bacteria; Bacteroidetes; Bacteroidia; Bacteroidales; Bacteroidaceae;
OC   Bacteroides.
OX   NCBI_TaxID=226186;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION IN CHONDROITIN SULFATE
RP   UTILIZATION.
RC   STRAIN=46-1, and CS3;
RX   PubMed=1429442; DOI=10.1128/jb.174.22.7185-7193.1992;
RA   Cheng Q., Hwa V., Salyers A.A.;
RT   "A locus that contributes to colonization of the intestinal tract by
RT   Bacteroides thetaiotaomicron contains a single regulatory gene (chuR) that
RT   links two polysaccharide utilization pathways.";
RL   J. Bacteriol. 174:7185-7193(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 /
RC   VPI-5482 / E50;
RX   PubMed=12663928; DOI=10.1126/science.1080029;
RA   Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C.,
RA   Hooper L.V., Gordon J.I.;
RT   "A genomic view of the human-Bacteroides thetaiotaomicron symbiosis.";
RL   Science 299:2074-2076(2003).
RN   [3]
RP   FUNCTION AS A SULFATASE-MATURATING ENZYME, CATALYTIC ACTIVITY, SUBSTRATE
RP   SPECIFICITY, COFACTOR, AND REACTION MECHANISM.
RC   STRAIN=ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 /
RC   VPI-5482 / E50;
RX   PubMed=18408004; DOI=10.1074/jbc.m710074200;
RA   Benjdia A., Subramanian S., Leprince J., Vaudry H., Johnson M.K.,
RA   Berteau O.;
RT   "Anaerobic sulfatase-maturating enzymes - first dual substrate radical S-
RT   adenosylmethionine enzymes.";
RL   J. Biol. Chem. 283:17815-17826(2008).
RN   [4]
RP   COFACTOR, AND MUTAGENESIS OF CYS-24; CYS-28; CYS-31; CYS-276; CYS-282;
RP   CYS-339; CYS-342 AND CYS-348.
RX   PubMed=20218986; DOI=10.1111/j.1742-4658.2010.07613.x;
RA   Benjdia A., Subramanian S., Leprince J., Vaudry H., Johnson M.K.,
RA   Berteau O.;
RT   "Anaerobic sulfatase-maturating enzyme--a mechanistic link with glycyl
RT   radical-activating enzymes?";
RL   FEBS J. 277:1906-1920(2010).
CC   -!- FUNCTION: Involved in 'Ser-type' sulfatase maturation under anaerobic
CC       conditions. Links the heparin and the chondroitin sulfate utilization
CC       pathways which contribute to the colonization of the intestinal tract.
CC       May catalyze the activation of chondro-6-sulfatase, i.e. the post-
CC       translational modification of a specific serine residue into 3-
CC       oxoalanine (also known as C(alpha)-formylglycine (FGly)), by a free
CC       radical chemical mechanism initiated via the reductive cleavage of S-
CC       adenosyl-L-methionine (SAM). Is also able to oxidize a cysteine residue
CC       in a synthetic substrate to FGly in vitro, but not in a recombinant
CC       Cys-type sulfatase in vivo. But since B.thetaiotaomicron possesses only
CC       Ser-type sulfatases, the oxidation of serine residues to FGly is the
CC       sole physiological activity. {ECO:0000269|PubMed:1429442,
CC       ECO:0000269|PubMed:18408004}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[sulfatase] + S-adenosyl-L-methionine = 3-oxo-L-
CC         alanyl-[sulfatase] + 5'-deoxyadenosine + H(+) + L-methionine;
CC         Xref=Rhea:RHEA:17609, Rhea:RHEA-COMP:12901, Rhea:RHEA-COMP:15882,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17319, ChEBI:CHEBI:29999,
CC         ChEBI:CHEBI:57844, ChEBI:CHEBI:59789, ChEBI:CHEBI:85621; EC=1.1.98.7;
CC         Evidence={ECO:0000269|PubMed:18408004};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU01266,
CC         ECO:0000269|PubMed:20218986, ECO:0000305|PubMed:18408004};
CC       Note=Binds 3 [4Fe-4S] clusters (PubMed:20218986). The first cluster is
CC       coordinated with 3 cysteines and an exchangeable S-adenosyl-L-
CC       methionine (By similarity). {ECO:0000250|UniProtKB:Q0TTH1,
CC       ECO:0000269|PubMed:20218986};
CC   -!- PATHWAY: Protein modification; sulfatase oxidation.
CC   -!- SIMILARITY: Belongs to the radical SAM superfamily. Anaerobic
CC       sulfatase-maturating enzyme family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L00678; AAA22908.1; -; Genomic_DNA.
DR   EMBL; AE015928; AAO75345.1; -; Genomic_DNA.
DR   PIR; A47014; A47014.
DR   RefSeq; NP_809151.1; NC_004663.1.
DR   RefSeq; WP_008766211.1; NC_004663.1.
DR   AlphaFoldDB; Q02550; -.
DR   SMR; Q02550; -.
DR   STRING; 226186.BT_0238; -.
DR   PaxDb; Q02550; -.
DR   PRIDE; Q02550; -.
DR   EnsemblBacteria; AAO75345; AAO75345; BT_0238.
DR   GeneID; 60926202; -.
DR   KEGG; bth:BT_0238; -.
DR   PATRIC; fig|226186.12.peg.239; -.
DR   eggNOG; COG0641; Bacteria.
DR   HOGENOM; CLU_009273_10_0_10; -.
DR   InParanoid; Q02550; -.
DR   OMA; YPCYRFV; -.
DR   BRENDA; 1.1.98.7; 709.
DR   UniPathway; UPA00910; -.
DR   Proteomes; UP000001414; Chromosome.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR023885; 4Fe4S-binding_SPASM_dom.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR034491; Anaerob_Ser_sulfatase-maturase.
DR   InterPro; IPR007197; rSAM.
DR   InterPro; IPR023867; Sulphatase_maturase_rSAM.
DR   PANTHER; PTHR43273; PTHR43273; 1.
DR   Pfam; PF04055; Radical_SAM; 1.
DR   Pfam; PF13186; SPASM; 1.
DR   SFLD; SFLDF00285; anaerobic_Ser-type_sulfatase-m; 1.
DR   SFLD; SFLDG01384; thioether_bond_formation_requi; 1.
DR   TIGRFAMs; TIGR04085; rSAM_more_4Fe4S; 1.
DR   PROSITE; PS51918; RADICAL_SAM; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Iron; Iron-sulfur; Metal-binding; Oxidoreductase;
KW   Reference proteome; S-adenosyl-L-methionine.
FT   CHAIN           1..414
FT                   /note="Serine-type anaerobic sulfatase-maturating enzyme"
FT                   /id="PRO_0000134462"
FT   DOMAIN          5..250
FT                   /note="Radical SAM core"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01266"
FT   ACT_SITE        298
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TTH1"
FT   BINDING         24
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="1"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01266,
FT                   ECO:0000305|PubMed:20218986"
FT   BINDING         28
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="1"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01266,
FT                   ECO:0000305|PubMed:20218986"
FT   BINDING         30
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TTH1"
FT   BINDING         31
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="1"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01266,
FT                   ECO:0000305|PubMed:20218986"
FT   BINDING         76
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TTH1"
FT   BINDING         131
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TTH1"
FT   BINDING         143
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TTH1"
FT   BINDING         276
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305|PubMed:20218986"
FT   BINDING         282
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305|PubMed:20218986"
FT   BINDING         297
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TTH1"
FT   BINDING         339
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000305|PubMed:20218986"
FT   BINDING         342
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000305|PubMed:20218986"
FT   BINDING         348
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000305|PubMed:20218986"
FT   BINDING         352
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TTH1"
FT   BINDING         371
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TTH1"
FT   MUTAGEN         24
FT                   /note="C->A: Still contains 4Fe-4S but lacks activity; when
FT                   associated with A-28 and A-31."
FT                   /evidence="ECO:0000269|PubMed:20218986"
FT   MUTAGEN         28
FT                   /note="C->A: Still contains 4Fe-4S but lacks activity; when
FT                   associated with A-24 and A-31."
FT                   /evidence="ECO:0000269|PubMed:20218986"
FT   MUTAGEN         31
FT                   /note="C->A: Still contains 4Fe-4S but lacks activity; when
FT                   associated with A-24 and A-28."
FT                   /evidence="ECO:0000269|PubMed:20218986"
FT   MUTAGEN         276
FT                   /note="C->A: Still contains 4Fe-4S but lacks activity; when
FT                   associated with A-282."
FT                   /evidence="ECO:0000269|PubMed:20218986"
FT   MUTAGEN         282
FT                   /note="C->A: Still contains 4Fe-4S but lacks activity; when
FT                   associated with A-276."
FT                   /evidence="ECO:0000269|PubMed:20218986"
FT   MUTAGEN         339
FT                   /note="C->A: Still contains 4Fe-4S but lacks activity; when
FT                   associated with A-342 and A-348."
FT                   /evidence="ECO:0000269|PubMed:20218986"
FT   MUTAGEN         342
FT                   /note="C->A: Still contains 4Fe-4S but lacks activity; when
FT                   associated with A-339 and A-348."
FT                   /evidence="ECO:0000269|PubMed:20218986"
FT   MUTAGEN         348
FT                   /note="C->A: Still contains 4Fe-4S but lacks activity; when
FT                   associated with A-339 and A-342."
FT                   /evidence="ECO:0000269|PubMed:20218986"
FT   CONFLICT        400..414
FT                   /note="NIMKALKDGSLKIEY -> TS (in Ref. 1; AAA22908)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   414 AA;  47949 MW;  F0FCC6B6DCDF34B5 CRC64;
     MKATTYAPFA KPLYVMVKPV GAVCNLACEY CYYLEKANLY KENPKHVMSD ELLEKFIDEY
     INSQTMPQVL FTWHGGETLM RPLSFYKKAM ELQKKYARGR TIDNCIQTNG TLLTDEWCEF
     FRENNWLVGV SIDGPQEFHD EYRKNKMGKP SFVKVMQGIN LLKKHGVEWN AMAVVNDFNA
     EYPLDFYNFF KEIDCHYIQF APIVERIVSH QDGRHLASLA EGKEGALADF SVSPEQWGNF
     LCTIFDEWVK EDVGKFFIQI FDSTLANWMG EQPGVCTMAK HCGHAGVMEF NGDVYSCDHF
     VFPEYKLGNI YSQTLVEMMH SERQHNFGTM KYQSLPTQCK ECDFLFACNG ECPKNRFSRT
     ADGEPGLNYL CKGYYQYFQH VAPYMDFMKK ELMNQQAPAN IMKALKDGSL KIEY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025